387 related articles for article (PubMed ID: 17786278)
1. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
Bank U; Tadje J; Täger M; Wolke C; Bukowska A; Ittenson A; Reinhold D; Helmuth M; Ansorge S; Shakespeare A; Vieth M; Malfertheiner P; Naumann M; Lendeckel U
Int J Mol Med; 2007 Oct; 20(4):483-92. PubMed ID: 17786278
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
4. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
7. Frequency of Foxp3+CD4CD25+ T cells is associated with the phenotypes of allergic asthma.
Matsumoto K; Inoue H; Fukuyama S; Kan-O K; Eguchi-Tsuda M; Matsumoto T; Moriwaki A; Nakano T; Nakanishi Y
Respirology; 2009 Mar; 14(2):187-94. PubMed ID: 19192224
[TBL] [Abstract][Full Text] [Related]
8. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
[TBL] [Abstract][Full Text] [Related]
9. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
11. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
12. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
Liu Y; Amarnath S; Chen W
Transplantation; 2006 Oct; 82(7):953-64. PubMed ID: 17038912
[TBL] [Abstract][Full Text] [Related]
13. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
14. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
[TBL] [Abstract][Full Text] [Related]
15. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells.
Hendrikx TK; van Gurp EA; Mol WM; Schoordijk W; Sewgobind VD; Ijzermans JN; Weimar W; Baan CC
Nephrol Dial Transplant; 2009 Jun; 24(6):1969-78. PubMed ID: 19193737
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
17. The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent.
Gunnlaugsdottir B; Maggadottir SM; Skaftadottir I; Ludviksson BR
Scand J Immunol; 2013 Feb; 77(2):125-34. PubMed ID: 23126599
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
[TBL] [Abstract][Full Text] [Related]
19. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
Qiao M; Thornton AM; Shevach EM
Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease.
Mahajan D; Wang Y; Qin X; Wang Y; Zheng G; Wang YM; Alexander SI; Harris DC
J Am Soc Nephrol; 2006 Oct; 17(10):2731-41. PubMed ID: 16988067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
